Hi Tota,
Further to this piece of advise
1) " Some advice I was given many years ago was ' never invest in something you do not fully understand' !! It remains sound advice in any investment decisions imo."
I'm pretty sure that it is the business model that needs to be understood, not technical details. Investing in biotechs might become even more difficult, if you need to be able to replicate trial clinical trial behaviour in your kitchen.
I realise that you took that from another post, but I can't see it which does make me feel like a weight has been lifted from my shoulders.
chart for march 2011, page-23
-
- There are more pages in this discussion • 13 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VYS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.020(4.12%) |
Mkt cap ! $196.2M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 48.0¢ | 44.0¢ | $1.456M | 3.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 44917 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 109054 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| VYS (ASX) Chart |